NFKB1 and Hyperglycemia: Hyperglycemia also influences the SUMOylation of IκBα, which is the main inhibitor of NF-κB dimers: when IκBα is SUMOylated, it is resistant to ubiquitin-induced degradation, and it inhibits NF-κB.